OAS3
OAS3 (2'-5'-oligoadenylate synthetase 3) is an interferon-induced, dsRNA-activated enzyme that contributes to the innate antiviral response. It synthesises 2'-5'-oligoadenylates that activate RNase L, and belongs to the 2-5A synthase family. Browse Assay Genie's current range of OAS3 research reagents below, or read on for the biology behind the target.
OAS3 is an interferon-induced antiviral enzyme that is activated by double-stranded RNA and plays a critical role in the cellular innate antiviral response. It preferentially catalyses the dimerisation of ATP to form 2'-5'-diadenylate (2-5A), although it can also form the trimeric 2'-5'-oligoadenylate. These oligoadenylates bind the inactive monomeric form of ribonuclease L (RNase L), causing its dimerisation and activation.
Activated RNase L degrades both cellular and viral RNA, which inhibits protein synthesis and so terminates viral replication. OAS3 can mediate its antiviral effect through this classical RNase L-dependent pathway or through an alternative pathway that does not depend on RNase L. Antiviral activity has been reported against Chikungunya virus (CHIKV), Dengue virus, Sindbis virus (SINV) and Semliki forest virus (SFV). UniProt also notes that the enzyme may play a role in apoptosis, cell growth, differentiation and gene regulation.
The OAS3 gene encodes a member of the 2'-5'-oligoadenylate synthetase family, and the protein is found in the cytoplasm and the nucleus. The family as a whole is important in inhibiting cellular protein synthesis and in resistance to viral infection. The protein was previously named 2'-5'-oligoadenylate synthetase 3 (100 kD), and mouse and rat each carry an Oas3 ortholog, which supports comparative work on interferon-driven antiviral responses.
OAS3 is an interferon-induced, dsRNA-activated enzyme with a critical role in the cellular innate antiviral response.
OAS3 produces 2-5A oligoadenylates that dimerise and activate RNase L, leading to RNA degradation and inhibition of protein synthesis.
OAS3 shows antiviral activity against Chikungunya, Dengue, Sindbis and Semliki forest viruses, via RNase L-dependent and independent routes.
UniProt notes that OAS3 may also contribute to apoptosis, cell growth, differentiation and gene regulation beyond its antiviral role.
OAS3 is activated by double-stranded RNA and catalyses the formation of 2'-5'-oligoadenylates from ATP, mainly 2-5A dimers. These bind and activate RNase L, which degrades cellular and viral RNA and halts protein synthesis, terminating viral replication. It can also act through an RNase L-independent pathway.
The HGNC name is 2'-5'-oligoadenylate synthetase 3, and UniProt lists 2'-5'-oligoadenylate synthase 3. Earlier names include 2'-5'-oligoadenylate synthetase 3 (100 kD) and 2'-5'-oligoadenylate synthetase 3, 100kDa. No alternative gene symbols are recorded. The enzyme is classified as EC 2.7.7.84.
Yes. Both mouse and rat have an ortholog named Oas3, so the interferon-induced 2-5A pathway can be studied in rodent models. OAS3 belongs to the 2-5A synthase family, alongside OAS1, OAS2 and OASL; check the datasheet of any product for its validated reactivity.
Other members of the 2-5A synthase family involved in interferon-induced antiviral responses.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y6K5; product specifications from Assay Genie datasheets.